Dr. Dimachkie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3599 Rainbow Blvd # Ms 2012
Kansas City, KS 66103Phone+1 913-588-0649Fax+1 913-588-0609- Is this information wrong?
Summary
- Mazen M. Dimachkie, MD, FAAN, FANA, is Professor of Neurology, Director of the Clinical Neurophysiology Division and Director of the Neuromuscular Section, at the University of Kansas Medical Center (KUMC) in Kansas City, where he is also Director of the Clinical Neurophysiology Fellowship and Neuromuscular Medicine Fellowship programs. As the director of KUMC Neuromuscular Research, he manages one of the busiest neuromuscular clinical trials units in North America. He is also Associate Director of the Heartland Unit for Neuroscience Trials as part of the KUMC participation in the NINDS Network for Excellence in Neuroscience Clinical Trials known as NeuroNEXT. He received his medical degree from the American University of Beirut in Lebanon before completing an internship in Internal Medicine at Saint Agnes Hospital in Baltimore, Maryland. Dr. Dimachkie then completed a residency in Neurology and a fellowship in Neuromuscular Disease at The University of Texas Health Science Center at Houston. He is board-certified in Neurology, Clinical Neurophysiology and Neuromuscular Medicine.
Dr. Dimachkie is a member of the American Neurological Association (Fellow member), American Academy of Neurology (Fellow member), American Association of Neuromuscular & Electrodiagnostic Medicine, the Peripheral Nerve Society and The Neuropathy Association. He was elected as fellow member of the American Academy of Neurology and of the American Neurological Association. He is a frequently invited lecturer in the fields of neuromuscular neurology, and he has authored or co-authored more than 200 abstracts, articles, and book chapters. He is involved in a wide variety of federally-funded neuromuscular research studies as well industry-sponsored studies, nationally and internationally. Dr. Dimachkie’s neuromuscular research interests are broad and include amyotrophic lateral sclerosis, neuropathies, myasthenia gravis and myopathies.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Neuromuscular Medicine (Neurology), 1994 - 1995
- University of Texas Health Science Center at HoustonResidency, Neurology, 1990 - 1994
- St Agnes HealthCareResidency, Internal Medicine, 1988 - 1990
- American University of Beirut Faculty of MedicineClass of 1988
Certifications & Licensure
- MO State Medical License 2022 - 2025
- KS State Medical License 2007 - 2024
- TX State Medical License 1993 - 2009
- MD State Medical License 1989 - 2000
- OK State Medical License 1994 - 1996
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Fellow ANA
- Fellow AAN
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa Start of enrollment: 2008 Sep 01
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
- Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis Start of enrollment: 2015 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCorrespondence on 'Current myositis clinical trials and tribulations' by Saygin.Sofia Ferreira Azevedo, Antonia Valenzuela, Cristian Alejandro Benitez, David A Isenberg, Hector Chinoy, Jiří Vencovský, Latika Gupta, Liza McCann, Masataka Kuwana, Pe...> ;Annals of the Rheumatic Diseases. 2024 Mar 28
- 1 citationsPerformance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.Didem Saygin, Stefanie Glaubitz, Rachel Zeng, Matteo Bottai, Marianne de Visser, Mazen M Dimachkie, David Fiorentino, Ingrid Gerhardson, Masataka Kuwana, Frederick W M...> ;Clinical and Experimental Rheumatology. 2024 Feb 1
- Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis.Sharfaraz Salam, Jodi Allen, Mazen M Dimachkie, Michael G Hanna, Pedro M Machado> ;Clinical and Experimental Rheumatology. 2024 Feb 1
- Join now to see all
Journal Articles
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)Richard J Barohn, Mamatha Pasnoor, Omar Jawdat, Mazen M Dimachkie, JAMA Neurology
Authored Content
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
Press Mentions
- NEJM Article Releases Positive Results of Clinical Trial Investigating Treatment for Rare Inflammatory Disease, DermatomyositisNovember 22nd, 2022
- American Association of Neuromuscular & Electrodiagnostic MedicineJuly 3rd, 2019
Professional Memberships
- Fellow
- Member
Other Languages
- Arabic, French
Hospital Affiliations
- The University of Kansas HospitalKansas City, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: